Psoriasis is a chronic inflammatory disorder affecting 3% of the population. The objective of our study was to provide prevalence estimates for inflammatory back pain (IBP) and spondyloarthritis (SpA) in those subjects with psoriasis using 2009-2010 NHANES data.
INTRODUCTION
Psoriasis is a prevalent, chronic inflammatory disorder of the skin most often characterized by the development of distinctive erythematous papules and plaques with overlying scale.
Worldwide, psoriasis prevalence rates range from 0.6 percent to 4.8 percent and have remained stable since the mid-2000's (1-3). Population based surveys of diagnosed psoriasis in the US indicate a prevalence of 2.2-3.2% of adults, or between 4 and 5 million cases (4, 5) . Men and women are affected equally and there is a bimodal peak of onset at ages 20-30 and ages 50-60 (6) . It is estimated that 7-42% of patients with psoriasis develop psoriatic arthritis (PsA) (7) . PsA may precede the onset of rash and typical findings of PsA may occur without any history of psoriasis.
Psoriasis is associated with a range of systemic comorbidities, including a wide spectrum of inflammatory musculoskeletal features, which are prevalent and frequently associated with chronic pain and functional impairment. Musculoskeletal symptoms include pain and stiffness in the peripheral joints, axial spine and soft tissues. Several different subsets of joint inflammation have been described in patients with PsA (8-10); however, patterns in those not meeting formal criteria for PsA are not as well described. Axial arthritis has also been widely reported although it is less frequently observed than peripheral disease (11) (12) (13) . 
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In 2009-10, the US National Health and Nutrition Examination Survey (NHANES) fielded a population-based survey of chronic axial pain in adults. Data on a prior diagnosis of psoriasis was also collected. The objective of this study was to provide nationally representative prevalence estimates for axial spinal symptomatology, inflammatory back pain (IBP), and spondyloarthritis (SpA) according to accepted criteria in a nationally representative sample of self-reported medically diagnosed psoriasis cases (14) (15) (16) (17) .
METHODS
NHANES is a cross-sectional survey that monitors the health and nutrition of the civilian, non-institutionalized US population. Data collection includes in-person household interviews, standardized physical examinations, and biological specimen collection in the NHANES mobile exam centers. The NHANES survey sample is a complex, multistage, probability design. Each annual sample is nationally representative; however, NHANES data are publicly released for 2-year survey periods to protect confidentiality and to increase sample sizes and statistical reliability.
The 2009-10 NHANES survey design included oversampling of major US demographic subgroups such as Hispanics and non-Hispanic black persons and those with low income (14, 18) . In the NHANES 2009-10 surveys, 6,684 persons in the study target age range of 20-69 years were screened for participation; 5,103 (76.3%) were interviewed and 5,001 (74.8%) were examined.
Demographic data collected in the household interview included age, gender and self-designated race-ethnicity. The demographic distribution of the study sample by age, gender, race/ethnicity, and chronic back pain characteristics has been described previously (15) .
Study Variables
The case definition of psoriasis is a self-reported prior medical diagnosis of psoriasis in the NHANES household interview and/or a prior medical diagnosis of psoriatic arthritis. In our paper, we will refer to self-reported medically diagnosed psoriasis cases as psoriasis cases. NHANES 2009-10 included a specially designed survey questionnaire for inflammatory back pain (IBP) and criteria sets 8a and 7b (22) . As described previously (16) , data were also collected to estimate lower bound estimates for two principal published SpA classification criteria: Amor et al. (23) and the ESSG (21) . A summary variable was created to identify the set of cases that were positive for either the Amor et al. or ESSG SpA criteria. The more recent Assessment of SpondyloArthritis international Society (ASAS) Criteria for SpA published after the NHANES had been fielded, are not included (24) .
Detailed documentation of the NHANES 2009-10 arthritis data collection and protocol has been published (17, 19) . If a survey participant had a prior history of neck, upper, mid or lower back or buttock pain 6 weeks in a row as shown on the NHANES axial pain diagram (25), then he/she was administered the full IBP/SpA screening questionnaire. Those who did not meet this criterion were administered a shorter version of the questionnaire (heel pain and history of prior medical diagnosis for SpA-related diseases). The 6-week pain duration criterion was selected because it is commonly used in primary care and orthopedic practice to differentiate between acute and chronic back pain (26, 27) . In addition, the 6-week back pain criterion was used previously in NHANES I and performed well. A subset of persons with chronic axial pain on most days for three months in a row, the most common criteria for chronic arthritic pain in rheumatology research, was also identified. As previously described for this study sample (15) , both the 6-week and 3-month criteria identify persons with a history of long-term chronic persistent or chronic intermittent axial pain. Unless otherwise specified, results are based on the 6-week duration criteria to maximize analytic sample sizes.
The analysis provides population prevalence estimates of IBP and SpA subjects with and without diagnosed psoriasis as well as prevalence estimates of individual IBP and SpA indicator variables among those with chronic axial pain (i.e. history of morning stiffness, response of axial 
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pain to exercise, rest and/or NSAIDs; history of heel pain, plantar fasciitis, etc.). Heel pain data was collected using specially designed diagrams to indicate pain in the plantar aspect of the hind-foot and the calcaneal tendon area most characteristic for plantar fasciitis and calcaneal tendonitis (25).
A participant's history of heel pain was considered positive if the episode lasted 2 weeks or longer.
Although the data collection did not include peripheral joint symptoms, NHANES questionnaire items relating to functional limitations due to arthritis and impairments of the arms and legs, and current prescription medication data were also analyzed.
Statistical Analysis
Interview and examination sample weights were employed to account for differential probabilities of selection within the complex NHANES sample design and to estimate prevalence odds ratio for population studies was calculated using the method of Graubard et al. (28) . The NHANES analytic guidelines criteria were used to set criteria for minimum acceptable sample sizes (based on design effect and specified proportions) and relative standard errors (RSE) to assess statistical stability of computed estimates. Estimates with RSE > 30% and sample sizes less than recommended is presented, however they are designated as potentially unreliable in the tables and should be interpreted with caution (28, 29) .
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RESULTS
There were 148 participants aged 20-69 who reported a prior diagnosis of psoriasis.
Additionally, there were 8 participants who reported a medical diagnosis of PsA. Three of these reported a diagnosis of psoriasis skin disease. In the final analytic sample therefore, there were 153 cases of either self-reported medically diagnosed psoriasis or PsA and 4,950 persons without a diagnosis of either disease. Demographic data for the study sample is provided in Table 1 .
Overall, almost one third of US adults reported a history of chronic axial pain. The prevalence of chronic axial pain using the 6-week pain episode criterion was 39.6% (95%CI 25.5-53.6); and for the 3-month criterion the prevalence was 31.1% (95%CI 17.2-20). The characteristics of both groups were similar: almost 90% in each group reported having current axial pain; the mean duration of axial pain for both was 13.2 years; 96% had pain duration greater than one year; and 45% had pain duration more than 10 years.
Chronic axial pain prevalence overall and by specific location is presented in Table 2 for those with and without psoriasis-related disease. Overall, there was not a statistically significant difference in axial pain between those with and those without psoriasis using the 6-week duration criterion (39.6% vs. 27.2%; p=0.07). There was, however, a significant difference between the two groups using the 3-month duration criterion (31.1% vs. 18.9%; p=0.04). There were also significant differences between the two groups at selected axial pain locations. Using the 6-week criterion, the psoriasis group had significantly greater lower lumbar area pain (32.5% vs. 18.6%; p=0.03) and buttocks area pain (13.1% vs. 8.4%; p=0.02). Using the 3-month criterion, there were no significant differences in lower lumbar area pain prevalence (23.4% vs. 13.0%; p=0.09), but there was a significant difference in buttocks area pain (9.8% vs. 6.1%; p=0.05). Alternating buttock pain was significantly more prevalent in psoriasis cases vs. those without psoriasis: 7.6% vs. 2.7% (p=0.03) at 6 weeks and 7.2% vs. 2.4% (p=0.03) at three months. Table 3 provides prevalence data for selected IBP indicator variables for those with and without psoriasis using the 6-week pain duration criteria. In both groups, the majority of persons Approximately 15% of psoriasis cases had gradual or "insidious" onset axial pain and its prevalence in the psoriasis group was not significantly different from that in the non-psoriasis axial pain group. The rapid development of axial pain within one hour to a day was significantly higher in the psoriasis group (23.3% vs. 13.0%; p=0.01). There were no significant differences between the psoriasis group and those without psoriasis for the other IBP indicators: history of spinal morning stiffness, being awakened from sleep by pain, increase in axial pain with with sleep or decrease in pain with exercise. Using the Amor classification criteria for SpA, the psoriasis group had significantly higher SpA prevalence than the non-psoriasis comparison group (8.6% vs. 0.6%; p=0.001) as was the case for the ESSG SpA classification criteria (9.3% vs. 1.1%; p=0.01). When the two criteria were combined, 14.3% of the psoriasis group met the criteria for either the Amor or the ESSG SpA criteria, whereas only 1.5% of the non-psoriasis group met one of the two SpA criteria (p<0.001).
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In the psoriasis group, 9.4% had a prior heel pain episode lasting two weeks or more at the plantar aspect of the hind-foot and/or in the calcaneal tendon area that was not due to injury. This was significantly higher than the 4.2% in the non-psoriasis group (p=0.03).
DISCUSSION
The primary study objective was to provide US population-based prevalence estimates for axial spinal symptomatology, IBP, SpA and selected co-morbidities among self-reported medically diagnosed psoriasis cases. The prevalence of axial pain in this group is: 40% for those with selfreported medically diagnosed psoriasis and 27% for those without.
The use of the 6-week pain duration criterion in our study originates from the evaluation of 
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the finding that the majority of persons with psoriasis and back pain were less than 45 years old also supports an inflammatory etiology.
With respect to the temporal pattern of axial pain onset, the original case definitions emphasized a gradual or "insidious" onset and development of inflammatory back pain (20). In contrast, we found gradual onset of axial pain that increased in intensity over a period of a year or more was the least common presentation. Instead, acute onset of axial pain over the course of a day was the most common pattern seen in both groups: among those subjects with chronic axial pain, it was observed in 61% of psoriasis cases and 52% of those without psoriasis. It should be noted, however, that this pattern was significantly increased in the psoriasis group. In general, when sudden-onset back pain is reported in primary care clinics, the differential diagnosis is broad and includes, but is not limited to, degenerative disc disease, osteoporotic changes or other mechanical etiologies. As the majority of persons who reported sudden-onset pain were under 45 years of age, this makes any age-related etiologies less likely. These results, at least for psoriasis cases, may challenge the validity of the current term "insidious" in the description of IBP. The onset of pain -insidious or sudden-onset -is subjective and it is important to recognize that these results may be subject to recall bias. Interestingly, when the IBP criteria were applied, including Calin, ESSG, Berlin 7b and 8a criteria, the psoriasis group met only the two Berlin criteria for IBP. This is likely because in the Berlin 7b criteria the definition does not include "insidious" onset but does include age-at-onset, duration of pain, morning stiffness and improvement with activity. Also, the Berlin 8a criteria are similar and in addition include alternating buttock pain, which in our data appears to be associated with psoriasis. Furthermore, this supports buttock pain as one of the more relevant, specific clinical indicators of inflammatory back pain (32) . This is helpful in identifying IBP in patients previously diagnosed with psoriasis who present to primary care clinics with chronic back pain.
A limitation of this study is the lack of a formal validation of self-reported medical provider diagnosis of psoriasis. In prior published work, it is generally considered that a history of the self- Previous National Center for Health Statistics studies on the validity of interview self-reports of chronic dermatitis (i.e. lasting 3 or more months) against medical records showed a significant degree of under reporting on the part of interviewees (41) . If this effect were operative specifically for psoriasis in the current study, it would bias study associations towards the null, as a proportion of actual psoriasis cases would be assigned to the "no psoriasis" normal reference group. Similarly, any undiagnosed psoriasis cases are by definition included in the "normal" reference group, which would further magnify this bias. These latter effects could actually serve to strengthen the validity of the positive associations between axial disease and psoriasis found in the current report (22) . 
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This article is protected by copyright. All rights reserved. Abbreviations: IBP= Inflammatory Back Pain; N=sample size; n=number of cases; CI= confidence interval; p= T-test significance levels.
*Population-level analysis N= 5103; analysis based on variable for ever had axial pain episode for 6 weeks (neck, upper, mid, low back, or buttocks).
** Estimate does not meet criteria for statistical reliability.
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